| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a9e6421e9257148abad101e1ce6c162 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-0071
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-435 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 |
| filingDate |
2006-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f22544ec1cfd67684f9ee1f7aadcb870
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_192b203563abe67a9ed84666994268df |
| publicationDate |
2011-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
BR-PI0617304-A2 |
| titleOfInvention |
egln2 variants and their use in the prevention or treatment of thromboembolic diseases and coronary diseases |
| abstract |
EGLN2 VARIANTS AND USE OF THE SAME IN THE PREVENTION OR TREATMENT OF THROMBOEMBOLIC DISEASES AND CORONARY DISEASES. The present invention relates to human EGLN2 variants with a serine or leucine at position 58 of the amino acid sequence and their use in the prevention or treatment of thromboembolic diseases or coronary heart disease, especially stroke, prolonged reversible ischemic neurological deficiency (PRIND ), transient ischemic attack (TIA), myocardial infarction and / or premature myocardial infarction. |
| priorityDate |
2005-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |